OS Therapies OSTX Chief Operating Decision Maker — Nonoperating Income Expense

Similar metrics at other companies

MLROperating And Nonoperating Income Expense

$24.08M+4.0%

CWCOCorporate — Nonoperating Income Expense

$243.97K-18.9%

CODACorporate — Nonoperating Income Expense

$5.16K-83.9%

STEXCorporate — Nonoperating Income Expense

-$11.51M-6,357%

JAN

JANCorporate And Other — Nonoperating Income Expense

-$100.81M-18,500%

LODECorporate And Other — Nonoperating Income Expense

-$458.27K-9.2%

Questions, answered.

What is OS Therapies's chief operating decision maker — nonoperating income expense?

OS Therapies (OSTX) reported chief operating decision maker — nonoperating income expense of -$228.89K in Q1 2026.

How has OS Therapies's chief operating decision maker — nonoperating income expense changed year-over-year?

OS Therapies's chief operating decision maker — nonoperating income expense decreased by 120.4% year-over-year, from $1.12M to -$228.89K.

What does chief operating decision maker — nonoperating income expense mean?

The net total of all income and expenses that fall outside of the company's core clinical and administrative operations. This aggregate figure captures the impact of financing activities, investment returns, and other peripheral financial events. It is a critical component for reconciling operating performance to net income.